161 related articles for article (PubMed ID: 34708773)
1. Validation of choroidal hyperreflective foci in diabetic macular edema through a retrospective pilot study.
Saurabh K; Roy R; Herekar S; Mistry S; Choudhari S
Indian J Ophthalmol; 2021 Nov; 69(11):3203-3206. PubMed ID: 34708773
[TBL] [Abstract][Full Text] [Related]
2. Temporal variation of optical coherence tomography biomarkers as predictors of anti-VEGF treatment outcomes in diabetic macular edema.
Maggio E; Mete M; Sartore M; Bauci F; Guerriero M; Polito A; Pertile G
Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):807-815. PubMed ID: 34661731
[TBL] [Abstract][Full Text] [Related]
3. Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment.
Tang L; Luo D; Qiu Q; Xu GT; Zhang J
Ophthalmic Res; 2023; 66(1):39-47. PubMed ID: 35697006
[TBL] [Abstract][Full Text] [Related]
4. Choroidal Hyperreflective Foci: A Novel Spectral Domain Optical Coherence Tomography Biomarker in Eyes With Diabetic Macular Edema.
Roy R; Saurabh K; Shah D; Chowdhury M; Goel S
Asia Pac J Ophthalmol (Phila); 2019; 8(4):314-318. PubMed ID: 31397675
[TBL] [Abstract][Full Text] [Related]
5. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
[TBL] [Abstract][Full Text] [Related]
6. Optical Coherence Tomography-Based Grading of Diabetic Macular Edema Is Associated with Systemic Inflammatory Indices and Imaging Biomarkers.
Yanxia C; Xiongyi Y; Min F; Xiaoyun K
Ophthalmic Res; 2024; 67(1):96-106. PubMed ID: 38211574
[TBL] [Abstract][Full Text] [Related]
7. Hyperreflective foci as biomarkers for inflammation in diabetic macular edema: Retrospective analysis of treatment naïve eyes from south India.
Arthi M; Sindal MD; Rashmita R
Indian J Ophthalmol; 2021 May; 69(5):1197-1202. PubMed ID: 33913858
[TBL] [Abstract][Full Text] [Related]
8. CORRELATION OF OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI WITH VISUAL OUTCOMES IN DIFFERENT PATTERNS OF DIABETIC MACULAR EDEMA.
Kang JW; Chung H; Chan Kim H
Retina; 2016 Sep; 36(9):1630-9. PubMed ID: 26900741
[TBL] [Abstract][Full Text] [Related]
9. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS OF RETINAL HYPERPERMEABILITY AND CHOROIDAL INFLAMMATION AS PREDICTORS OF SHORT-TERM FUNCTIONAL AND ANATOMICAL OUTCOMES IN EYES WITH DIABETIC MACULAR EDEMA TREATED WITH INTRAVITREAL BEVACIZUMAB.
Mazloumi M; Entezari M; Samadikhadem S; Ramezani A; Nikkhah H; Arevalo JF
Retina; 2022 Apr; 42(4):760-766. PubMed ID: 35350050
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hyperreflective foci in macular edema secondary to multiple etiologies with spectral-domain optical coherence tomography: An observational study.
Zhu R; Xiao S; Zhang W; Li J; Yang M; Zhang Y; Gu X; Yang L
BMC Ophthalmol; 2022 Aug; 22(1):352. PubMed ID: 36038824
[TBL] [Abstract][Full Text] [Related]
11. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
Tang F; Qin X; Lu J; Song P; Li M; Ma X
Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
[TBL] [Abstract][Full Text] [Related]
12. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
Ozsaygili C; Duru N
Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
[TBL] [Abstract][Full Text] [Related]
13. Does dexamethasone implant combination with aflibercept monotherapy affect one-year outcomes in treatment-naive diabetic macular edema with inflammatory biomarkers?
Ozsaygılı C; Bayram N
Int Ophthalmol; 2024 Feb; 44(1):51. PubMed ID: 38336941
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial.
Rodrigues MW; Cardillo JA; Messias A; Siqueira RC; Scott IU; Jorge R
Graefes Arch Clin Exp Ophthalmol; 2020 Mar; 258(3):479-490. PubMed ID: 31873786
[TBL] [Abstract][Full Text] [Related]
15. Association between characteristics of foveal cystoid spaces and short-term responsiveness to ranibizumab for diabetic macular edema.
Murakami T; Suzuma K; Uji A; Yoshitake S; Dodo Y; Fujimoto M; Yoshitake T; Miwa Y; Yoshimura N
Jpn J Ophthalmol; 2018 May; 62(3):292-301. PubMed ID: 29460019
[TBL] [Abstract][Full Text] [Related]
16. Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy.
Huang CH; Yang CH; Hsieh YT; Yang CM; Ho TC; Lai TT
Sci Rep; 2021 Mar; 11(1):5103. PubMed ID: 33658601
[TBL] [Abstract][Full Text] [Related]
17. Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China.
Liu S; Wang D; Chen F; Zhang X
BMC Ophthalmol; 2019 Jul; 19(1):157. PubMed ID: 31337360
[TBL] [Abstract][Full Text] [Related]
18. Real-life anti-vascular endothelial growth factor treatment for age-related macular degeneration and diabetic macular edema in an Italian tertiary referral hospital.
Battaglia Parodi M; Romano F; Arrigo A; Sacchi R; Scanzi G; Ferri C; Bandello F
Eur J Ophthalmol; 2020 Nov; 30(6):1461-1466. PubMed ID: 31617403
[TBL] [Abstract][Full Text] [Related]
19. Treatment results of diabetic macular edema with different choroidal thickness with intravitreal anti vascular endothelial growth factor.
Savur F; Kaldırım H; Atalay K; Öğreden T; Hayat ŞÇ
BMC Ophthalmol; 2022 Dec; 22(1):508. PubMed ID: 36550418
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
